Julie Tetzlaff PhD Online Profile

Julie Tetzlaff PhD

Assistant Professor
Medical College of Wisconsin
Department: Pathology
Division: Administration


Research Experience

  • Autistic Disorder
  • Biological Markers
  • Drug Approval
  • Drug Evaluation, Preclinical
  • Fragile X Syndrome
  • Hemangioma
  • Neurosciences
  • Parkinson Disease
  • Receptors, Metabotropic Glutamate
  • Sudden Infant Death
  • alpha-Synuclein
  • Methodologies and Techniques

  • Behavioral Research
  • Blotting, Western
  • Cell Culture Techniques
  • Enzyme-Linked Immunosorbent Assay
  • Facial Nerve Injuries
  • Immunohistochemistry
  • Leadership Positions

  • Co-Founder and President elect of the Massachusetts General Hospital Postdoctoral Association (2007-2008)
  • Scientific Coordinator of the WI SIDS Research Center (2011-Present)
  • Educational Expertise

  • Neurosciences
  • Community Partnerships

  • Medical Examiner (Milwaukee County)
  • Publications

  • Dopamine-induced conformational changes in alpha-synuclein. (Outeiro TF, Klucken J, Bercury K, Tetzlaff J, Putcha P, Oliveira LM, Quintas A, McLean PJ, Hyman BT) PLoS One 2009;4(9):e6906 PMID 19730729
  • CHIP targets toxic alpha-Synuclein oligomers for degradation. (Tetzlaff JE, Putcha P, Outeiro TF, Ivanov A, Berezovska O, Hyman BT, McLean PJ) J Biol Chem 2008 Jun 27;283(26):17962-8 PMID 18436529
  • Formation of toxic oligomeric alpha-synuclein species in living cells. (Outeiro TF, Putcha P, Tetzlaff JE, Spoelgen R, Koker M, Carvalho F, Hyman BT, McLean PJ) PLoS One 2008;3(4):e1867 PMID 18382657
  • Cellular localization of androgen and estrogen receptors in mouse-derived motoneuron hybrid cells and mouse facial motoneurons. (Tetzlaff J, Tanzer L, Jones KJ) Dev Neurobiol 2007 Sep 1;67(10):1362-70 PMID 17638386
  • Exogenous androgen treatment delays the stress response following hamster facial nerve injury. (Tetzlaff J, Tanzer L, Jones KJ) J Neuroendocrinol 2007 May;19(5):383-9 PMID 17425613
  • Motoneuron injury and repair: New perspectives on gonadal steroids as neurotherapeutics. (Tetzlaff JE, Huppenbauer CB, Tanzer L, Alexander TD, Jones KJ) J Mol Neurosci 2006;28(1):53-64 PMID 16632875
  • Paroxetine is effective in desensitizing 5-HT1A receptor function in adult offspring exposed prenatally to cocaine. (Chen Z, Tetzlaff J, Sripathirathan K, Carrasco GA, Shankaran M, Van De Kar LD, Muma NA, Battaglia G) Psychopharmacology (Berl) 2005 Jul;180(2):316-26 PMID 15864558
  • Functional recovery after facial nerve crush is delayed in severe combined immunodeficient mice. (Serpe CJ, Tetzlaff JE, Coers S, Sanders VM, Jones KJ) Brain Behav Immun 2002 Dec;16(6):808-12 PMID 12480509
  • Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (-)DOI. (Zhang Y, Damjanoska KJ, Carrasco GA, Dudas B, D'Souza DN, Tetzlaff J, Garcia F, Hanley NR, Scripathirathan K, Petersen BR, Gray TS, Battaglia G, Muma NA, Van de Kar LD) J Neurosci 2002 Nov 1;22(21):9635-42 PMID 12417689
  • Effects of hippocampal injections of a novel ligand selective for the alpha 5 beta 2 gamma 2 subunits of the GABA/benzodiazepine receptor on Pavlovian conditioning. (Bailey DJ, Tetzlaff JE, Cook JM, He X, Helmstetter FJ) Neurobiol Learn Mem 2002 Jul;78(1):1-10 PMID 12071663